# Nigrostriatal Degeneration Underpins Sensorimotor Dysfunction in an Inducible Mouse Model of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)

**Authors:** Emre Kul, Mónica Santos, Oliver Stork

PMC · DOI: 10.3390/ijms26041511 · International Journal of Molecular Sciences · 2025-02-11

## TL;DR

This study shows that degeneration in the nigrostriatal pathway causes sensorimotor issues in a mouse model of FXTAS, a neurodegenerative disorder.

## Contribution

The study is the first to report nigrostriatal degeneration in an animal model of FXTAS, linking it to sensorimotor deficits.

## Key findings

- P90CGG mice showed late-onset impairments in prepulse inhibition after CGG repeat induction.
- Nigrostriatal degeneration was observed without inclusion formation in the substantia nigra.
- Sensorimotor gating deficits were linked to nigrostriatal pathway degeneration in FXTAS.

## Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by moderately expanded CGG trinucleotide repeats in the 5′ untranslated region (UTR) of the FMR1 gene. Characterized by motor deficits such as action tremor and cerebellar gait ataxia, FXTAS is further distinguished by ubiquitin-positive intranuclear inclusions in neurons and glia. However, its clinical spectrum often overlaps with other neurodegenerative conditions such as Parkinson’s disease (PD). Sensorimotor gating deficits, commonly associated with disorders affecting the nigrostriatal pathway such as PD, have been reported in FXTAS, but the underlying connection between these two phenotypes remains undetermined. In this study, we used the P90CGG mouse model of FXTAS, which expresses 90 CGG repeats upon doxycycline induction, to investigate sensorimotor gating deficits and their relationship to nigrostriatal degeneration. After induction, the P90CGG model exhibited late-onset impairments in prepulse inhibition (PPI), a cross-species measure of sensorimotor gating. These deficits coincided with pronounced nigrostriatal degeneration but occurred without evidence of inclusion formation in the substantia nigra. Our findings highlight nigrostriatal degeneration, which has not previously been reported in animal models of FXTAS, and suggest a potential link to sensorimotor gating dysfunction within the context of the disorder.

## Linked entities

- **Genes:** FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332]
- **Chemicals:** doxycycline (PubChem CID 54671203)
- **Diseases:** Fragile X-associated tremor/ataxia syndrome (MONDO:0010382), Parkinson’s disease (MONDO:0005180)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Fmr1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 14265] {aka FMRP, Fmr-1}
- **Diseases:** action tremor (MESH:D014202), PD (MESH:D010300), neurodegenerative conditions (MESH:D019636), Nigrostriatal Degeneration (MESH:D009410), Sensorimotor Dysfunction (MESH:D020233), FXTAS (MESH:C564105), motor deficits (MESH:D009461), cerebellar gait ataxia (MESH:D020234), gating dysfunction (MESH:D006331)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11855849/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11855849/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC11855849/full.md

---
Source: https://tomesphere.com/paper/PMC11855849